Study guide
6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders
ANCC Adult-Gerontology Primary Care Nurse Practitioner AGPCNP-BC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The AGPCNP-BC Examination: Blueprint, Format & Scoring
1.1 The AGPCNP-BC Blueprint, Exam Format, Scoring, Eligibility & Renewal
2 Chapter 2: Assessment Foundations & Lifespan Considerations
2.1 Comprehensive Health History, Symptom Analysis & Lifespan Variations 2.2 Physical Examination Techniques & Age-Related Physiological Changes 2.3 Functional Assessment (Katz ADL / Lawton IADL) & Frailty Syndromes 2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments 2.5 Health Screening Guidelines (USPSTF) & Adult Immunization Schedules (CDC/ACIP)
3 Chapter 3: Diagnostic Reasoning & Clinical Interpretation
3.1 Diagnostic Reasoning, Clinical Decision-Making & Differential Diagnosis Formulation 3.2 Routine & Specialized Laboratory Interpretation 3.3 Diagnostic Imaging, ECG Interpretation & Pulmonary Function Testing 3.4 Evidence-Based Testing, Pre-Test Probability & Choosing Wisely Principles
4 Chapter 4: Cardiovascular Disorders
4.1 Hypertension: 2025 AHA/ACC Guideline, Resistant HTN & Secondary HTN 4.2 Dyslipidemia & ASCVD Risk Calculation, Statin Therapy & Non-Statin Agents 4.3 Coronary Artery Disease, Stable Angina & Post-ACS Outpatient Management 4.4 Heart Failure (HFrEF/HFpEF), Atrial Fibrillation & Peripheral Vascular Disease
5 Chapter 5: Respiratory Disorders
5.1 Asthma: GINA 2026 Guidelines, Phenotypes, Stepwise Pharmacotherapy & Action Plans 5.2 COPD: GOLD 2026 Report, ABE Staging, Triple Inhalers & Exacerbations 5.3 Lower Respiratory Infections (CAP, Bronchitis), Pleural Disease & Solitary Pulmonary Nodules
6 Chapter 6: HEENT & Allergic/Immunologic Disorders
6.1 Eye & Vision Disorders in Adult-Gerontology Primary Care 6.2 Ear, Hearing & Vestibular Disorders 6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders 6.4 Allergic & Immunologic Disorders: Anaphylaxis, Urticaria, Angioedema & Immunodeficiency
7 Chapter 7: Endocrine & Metabolic Disorders
7.1 Type 2 Diabetes Mellitus: ADA Standards of Care, Pharmacotherapy & Microvascular Complications 7.2 Thyroid Disorders: Hypothyroidism, Hyperthyroidism, Thyroiditis & Nodules 7.3 Adrenal & Pituitary Disorders: Adrenal Insufficiency, Cushing's, Hyperaldosteronism & Hypopituitarism 7.4 Metabolic Bone Disease: Osteopenia, Osteoporosis (FRAX, DEXA) & Hyperparathyroidism
8 Chapter 8: Gastrointestinal & Hepatic Disorders
8.1 Upper GI Disorders: GERD, Barrett's Esophagus, PUD, H. pylori & Gastritis 8.2 Lower GI Disorders: Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) & Diverticular Disease 8.3 Hepatobiliary Disorders: MASLD/MASH, Viral & Alcoholic Hepatitis, Cirrhosis & Cholelithiasis 8.4 Acute & Chronic Abdominal Pain Syndromes, GI Bleeding & Colorectal Cancer Screening
9 Chapter 9: Renal, Urological & Men's Health
9.1 Chronic Kidney Disease: KDIGO Staging, Albuminuria Management & Renoprotective Strategies 9.2 Urinary Tract Infections (Uncomplicated, Complicated, Recurrent), Pyelonephritis & Microscopic Hematuria 9.3 Men's Health: Benign Prostatic Hyperplasia, Prostatitis, Epididymitis & Erectile Dysfunction
10 Chapter 10: Musculoskeletal & Rheumatologic Disorders
10.1 Degenerative & Overuse Musculoskeletal Disorders: Osteoarthritis, Tendinopathies & Spine Disorders 10.2 Autoimmune Rheumatologic Disorders: Rheumatoid Arthritis, SLE, Polymyalgia Rheumatica & Giant Cell Arteritis 10.3 Crystal Arthropathies & Fibromyalgia: Gout, Pseudogout & Centralized Pain Syndromes
11 Chapter 11: Neurological & Psychiatric Disorders
11.1 Headaches (Migraine, Tension, Cluster) & Cranial Neuralgias 11.2 Cerebrovascular Disease, TIA, Peripheral Neuropathies & Movement Disorders (Parkinson's) 11.3 Mood & Anxiety Disorders: Major Depressive Disorder, Generalized Anxiety Disorder & PTSD 11.4 Substance Use Disorders: Alcohol, Tobacco, Opioids & Cannabis in Primary Care
12 Chapter 12: Dermatologic, Hematologic & Infectious Disease
12.1 Primary Dermatologic Lesions, Inflammatory Dermatoses & Cutaneous Malignancies 12.2 Common Infectious Diseases: Skin/Soft Tissue Infections, Tick-Borne Illnesses & Viral Syndromes 12.3 Sexually Transmitted Infections (STIs): CDC Guidelines, Screening & Partner Management 12.4 Hematologic Disorders: Anemias (Microcytic, Normocytic, Macrocytic), Leukopenia & Coagulopathies
13 Chapter 13: Geriatric Syndromes, Pharmacology & Palliative Care
13.1 The Geriatric 5Ms Framework, Multimorbidity & Polypharmacy Deprescribing 13.2 Beers Criteria 2023 Update & STOPP/START Prescribing Rules 13.3 Pharmacokinetics, Pharmacodynamics & Pharmacogenomics Across the Adult Lifespan 13.4 Dementia vs. Delirium vs. Depression: Differential Diagnostics & Management 13.5 Falls, Mobility Impairment, Pressure Injury Prevention & Palliative Care Transitions
14 Chapter 14: Gynecologic & Women's Health
14.1 Contraceptive Management, Emergency Contraception & Preconception Counseling 14.2 Perimenopause, Menopause & Hormone Replacement Therapy (HRT) 14.3 Gynecologic Infections (Vaginitis, PID), Abnormal Uterine Bleeding & Cervical Cancer Screening (USPSTF/ASCCP)
15 Chapter 15: Plan-of-Care Process: Behavior Change, Education & Care Coordination
15.1 Behavioral Change: Motivational Interviewing, Models & Theories 15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment
16 Chapter 16: APRN Professional Practice, Ethics, Policy & Quality Improvement
16.1 APRN Scope of Practice, Consensus Model, Collaborative Practice & Credentialing 16.2 Bioethics, Informed Consent, Advance Directives & Surrogate Decision-Making 16.3 Environmental & Social Determinants of Health, Health Equity & Culturally Responsive Care 16.4 Evidence-Based Practice (EBP), Quality Improvement (QI) Methodologies & Healthcare Economics
6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders
Key Takeaways Explain This Topic AI
Acute bacterial rhinosinusitis is diagnosed by one of three temporal patterns: symptoms persisting 10 or more days without improvement, severe onset with fever of 39 degrees Celsius or higher plus purulent discharge for 3 to 4 days, or double worsening after initial improvement.
Amoxicillin-clavulanate is first-line for acute bacterial rhinosinusitis in adults; macrolides and trimethoprim-sulfamethoxazole are no longer recommended because of high pneumococcal resistance.
Group A streptococcal pharyngitis is treated with penicillin V or amoxicillin for 10 days, and a negative rapid antigen detection test in an adult does not require a confirmatory throat culture.
Intranasal corticosteroids are the single most effective monotherapy for allergic rhinitis and are more effective than oral antihistamines for nasal congestion.
Hoarseness persisting beyond 3 weeks, an oral lesion persisting beyond 2 weeks, unilateral nasal obstruction, or a persistent unilateral middle ear effusion in an adult all require referral for direct visualization or biopsy.
Last updated: August 2026
Nose, Sinus, Oropharyngeal & Oral Cavity Disorders
Upper respiratory complaints generate more primary care visits than any other category, and they generate more inappropriate antibiotic prescriptions than any other category. The AGPCNP examination tests whether you can apply explicit diagnostic criteria rather than treat symptoms, and whether you recognize the small set of upper aerodigestive findings that signal malignancy.
1. Rhinosinusitis: The Temporal Criteria
More than 98 percent of acute rhinosinusitis is viral . The distinction from bacterial disease is made by the pattern over time , not by the color of the discharge - purulent green or yellow mucus is produced by neutrophil myeloperoxidase and occurs in ordinary viral illness. +---------------------------------------------------------------------------------------------------+
- | ACUTE BACTERIAL RHINOSINUSITIS: ANY ONE OF THREE PATTERNS |
- | |
- | 1. PERSISTENT ..... Symptoms lasting >= 10 DAYS with NO improvement |
- | |
- | 2. SEVERE ......... Fever >= 39 degrees C (102.2 F) PLUS purulent nasal discharge or facial |
- | pain for at least 3 to 4 CONSECUTIVE days at the START of illness |
- | |
- | 3. WORSENING ...... "DOUBLE WORSENING" or "double sickening": new fever, headache or increased |
- | nasal discharge AFTER a typical viral URI that had begun to improve, |
- | usually on day 5 to 6 |
- | |
- | ACUTE = < 4 weeks | SUBACUTE = 4 to 12 weeks | CHRONIC = >= 12 weeks with objective |
- | inflammation on endoscopy or CT (and chronic disease requires imaging or endoscopy, not just |
- | symptom duration) |
- +---------------------------------------------------------------------------------------------------+
Treatment. For acute bacterial rhinosinusitis in adults, amoxicillin-clavulanate is first-line, typically 500/125 mg three times daily or 875/125 mg twice daily for 5 to 7 days. Watchful waiting with symptomatic care for up to 7 days is an acceptable alternative in reliable, non-toxic patients with adequate follow-up. For a documented type I penicillin allergy, use doxycycline or a respiratory fluoroquinolone (levofloxacin or moxifloxacin), reserving fluoroquinolones because of their tendon, neuropathy, aortic and central nervous system warnings. Macrolides and trimethoprim-sulfamethoxazole are no longer recommended because of high rates of pneumococcal resistance. Adjuncts: intranasal saline irrigation, intranasal corticosteroids (particularly with an allergic background), and analgesia. Oral decongestants raise blood pressure and are on the Beers list of drugs to avoid or use with caution in older adults; topical oxymetazoline must be limited to 3 days to avoid rhinitis medicamentosa.
Red flags demanding urgent imaging and referral: periorbital swelling or erythema, proptosis, ophthalmoplegia or vision change (orbital cellulitis), altered mental status or meningismus, severe unilateral headache, or forehead swelling (Pott puffy tumor). Immunocompromised or poorly controlled diabetic patients with black nasal eschar and facial numbness require emergency evaluation for invasive fungal sinusitis (mucormycosis) .
2. Allergic Rhinitis
Sneezing, clear rhinorrhea, nasal itching and congestion with pale boggy turbinates, allergic shiners and a transverse nasal crease. It coexists with asthma in a majority of asthmatic patients ("one airway, one disease"), and uncontrolled rhinitis worsens asthma control.
Therapy Role
Intranasal corticosteroid (fluticasone, mometasone, budesonide) Most effective monotherapy , and superior to oral antihistamines for congestion. Requires daily use for 1 to 2 weeks for full effect. Teach aiming away from the septum to prevent epistaxis and septal perforation.
Second-generation oral antihistamine (loratadine, cetirizine, fexofenadine) Good for sneezing, itching and rhinorrhea; weaker for congestion.
Intranasal antihistamine (azelastine) Rapid onset, useful as needed and additive to intranasal steroid.
Leukotriene receptor antagonist (montelukast) Second-line; carries an FDA boxed warning for serious neuropsychiatric events.
Allergen immunotherapy Disease-modifying; for inadequately controlled or polysensitized patients.
First-generation antihistamines (diphenhydramine, hydroxyzine, chlorpheniramine) Avoid , especially in older adults - Beers Criteria, anticholinergic burden, sedation, falls, delirium, urinary retention.
3. Pharyngitis
The purpose of evaluating a sore throat is to identify the roughly 5 to 15 percent of adult cases caused by group A Streptococcus , in order to prevent acute rheumatic fever and suppurative complications. +-----------------------------------------------------------------------------+
- | CENTOR CRITERIA (McIsaac modification adds age) |
- | |
- | +1 Tonsillar exudate or swelling |
- | +1 Tender ANTERIOR cervical lymphadenopathy |
- | +1 Fever by history (> 38 degrees C) |
- | +1 ABSENCE of cough |
- | ----------------------------------------------------------------------- |
- | McIsaac age modifier: +1 if age 3-14 | 0 if age 15-44 | -1 if age >= 45 |
- | |
- | SCORE 0 to 1 ...... No testing, no antibiotic. Symptomatic care. |
- | SCORE 2 to 3 ...... Rapid antigen detection test (RADT); treat if positive |
- | SCORE 4 to 5 ...... RADT; many still test rather than treat empirically |
- +-----------------------------------------------------------------------------+
Testing rule for adults. Per IDSA guidance, a negative RADT in an adult does not require a back-up throat culture , because the incidence of group A streptococcal pharyngitis and the risk of acute rheumatic fever are both low in adults. Children and adolescents do need a confirmatory culture after a negative RADT.
Treatment of confirmed group A streptococcal pharyngitis: penicillin V 500 mg two to three times daily, or amoxicillin 500 mg twice daily , for a full 10 days (a single dose of intramuscular benzathine penicillin G is an alternative). For non-anaphylactic penicillin allergy use a first-generation cephalosporin such as cephalexin; for anaphylactic allergy use clindamycin or azithromycin. Group A Streptococcus has never developed penicillin resistance , so a broad-spectrum agent is never required.
Do not miss:
Peritonsillar abscess: unilateral severe pain, trismus , a "hot potato" muffled voice, uvular deviation away from the swollen tonsil. Needs urgent otolaryngology or emergency evaluation for drainage.
Epiglottitis in an adult: rapid onset of severe odynophagia, drooling, muffled voice and stridor with an unimpressive oropharyngeal examination. Do not depress the tongue. Emergency airway management.
Infectious mononucleosis: posterior cervical adenopathy, marked fatigue, splenomegaly, atypical lymphocytosis and positive heterophile antibody. Avoid amoxicillin (morbilliform rash) and avoid contact sports for at least 3 to 4 weeks because of splenic rupture risk.
Acute HIV (retroviral) syndrome: fever, non-exudative pharyngitis, diffuse adenopathy, rash and mucocutaneous ulcers. Order an HIV RNA test, because antibody assays may still be negative.
Gonococcal pharyngitis: consider with a compatible sexual history; it is frequently asymptomatic.
4. Epistaxis
About 90 percent of bleeding is anterior , from Kiesselbach plexus on the anterior nasal septum.
Initial management: have the patient sit upright and lean forward (to avoid swallowing blood), blow out clots, apply oxymetazoline spray, and pinch the soft cartilaginous part of the nose - not the bony bridge - continuously for 10 to 15 minutes without releasing to check . If bleeding stops, apply petroleum-based ointment and humidification. If it persists, proceed to silver nitrate cautery of a visualized anterior bleeding point (never cauterize both sides of the septum at the same visit, which risks septal perforation) or anterior packing.
Posterior bleeding - profuse bleeding, blood in the posterior pharynx, failure to control with anterior measures - requires emergency referral. Reassess anticoagulants and antiplatelets, control hypertension, and consider hereditary hemorrhagic telangiectasia in recurrent cases with mucocutaneous telangiectasias and a family history.
5. Oral Cavity and Laryngeal Findings
Lesion Appearance Action
Leukoplakia White patch that cannot be scraped off Premalignant - biopsy. Address tobacco and alcohol.
Erythroplakia Red velvety patch Higher malignant potential than leukoplakia - biopsy promptly.
Oral candidiasis (thrush) White plaques that scrape off leaving an erythematous base Clotrimazole troches or nystatin; fluconazole if extensive. In an adult with no obvious cause, evaluate for inhaled-corticosteroid technique, diabetes, HIV or other immunosuppression.
Aphthous ulcer Shallow, painful, yellow-gray base with an erythematous halo, on non-keratinized mucosa Self-limited in 7 to 14 days. Recurrent, large or systemic cases: consider Behcet disease, celiac disease, inflammatory bowel disease, HIV, or iron, folate and B12 deficiency.
Oral lichen planus Lacy white Wickham striae , often bilateral buccal mucosa Chronic; topical corticosteroids; small malignant potential warrants periodic surveillance.
Herpes labialis Grouped vesicles on the vermilion border with prodromal tingling Oral antiviral started at prodrome.
Oropharyngeal squamous cell carcinoma Non-healing ulcer or mass, referred otalgia, painless neck node Rising incidence is driven by HPV type 16 , often in non-smokers. Any oral lesion persisting beyond 2 weeks requires biopsy.
Hoarseness (dysphonia). Most acute hoarseness is viral laryngitis; voice rest and hydration suffice. Hoarseness persisting more than 3 weeks requires laryngoscopy , and the threshold should be lower still with tobacco or alcohol use, a neck mass, dysphagia, odynophagia, stridor, hemoptysis, or a history of head and neck radiation. Chronic hoarseness also results from laryngopharyngeal reflux, inhaled corticosteroids without spacer use and rinsing, vocal cord nodules, hypothyroidism, and vocal cord paralysis from mediastinal, thyroid or intracranial pathology.
Screening note. The USPSTF concluded that evidence is insufficient (Grade I) to assess screening for oral cancer in asymptomatic adults. That is not a reason to skip oral inspection in a patient who uses tobacco or alcohol heavily; it means population screening lacks trial evidence.